Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer

被引：0
|
作者：
Streckert, I [1 ]
Bonatz, G. [2 ]
Kucharski, K. [3 ]
Marek, W.
Streckert, H. J.
Phillipou, S.
机构：
[1] Augusta Krankenanstalten, Inst Pathol & Zytol, Inst Pathol, Bochum, Germany
[2] Augusta Krankenanstalten, Bochum, Germany
[3] Malteser Krankenhaus St Anna, Brustzentrum Duisburg, Duisburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [31] uPA and PAI-1 in primary breast cancer:: from bench to bedside
    Harbeck, Nadia
    Jaenicke, Fritz
    Schmitt, Manfred
    Thomssen, Christoph
    EJC SUPPLEMENTS, 2004, 2 (03): : 26 - 27
  • [32] EVALUATION OF THE PROGNOSTIC/PREDICTIVE VALUE OF UPA/PAI-1 IN TRASTUZUMAB PRETREATED METASTATIC BREAST CANCER PATIENTS
    Koumarianou, A.
    Karayannopoulou, G.
    Eleftheraki, A. G.
    Batistatou, A.
    Bobos, M.
    Kalofonos, H. P.
    Bourli, A.
    Linardou, H.
    Kalogeras, K. T.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2011, 22 : 61 - 61
  • [33] PAI-1 and uPA as Biomarkers in Breast Cancer: From Pilot Studies to Recommendation for Clinical Use
    Duffy, M. J.
    TUMOR BIOLOGY, 2008, 29 : 25 - 25
  • [34] Health Care Management by Health Insurers; the Example of Biomarkers uPA/PAI-1 in nodal-negative Mammary Carcinoma: A new Approach to Implementation of Innovation and to Quality Improvement
    Jacobs, V. R.
    Kapitza, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
  • [35] Tumorbiological factors (uPA, PAI-1) as selection criteria for adjuvant chemotherapy in axillary node-negative breast cancer patients
    Jänicke, F
    Thomssen, C
    Harbeck, N
    Prechtl, A
    Berger, U
    Ulm, K
    Dettmar, P
    Pache, L
    Schmitt, M
    Graeff, H
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S24 - S25
  • [36] Adjuvant Chemotherapy in Node-negative Breast Cancer: UPA/PAI-1 Determinations for 163 Cases
    Venat-Bouvet, Laurence
    Fermeaux, Veronique
    Leobon, Sophie
    Saidi, Nadira
    Monteil, Jacques
    Mollard, Joelle
    Aubard, Yves
    Jammet, Isabelle
    Tubiana-Mathieu, Nicole
    ANTICANCER RESEARCH, 2014, 34 (03) : 1213 - 1217
  • [37] uPA and PAI-1 in Rectal Cancer - Relationship to Radiotherapy and Clinical Outcome
    Angenete, Eva
    Langenskiold, Marcus
    Palmgren, Ingrid
    Falk, Peter
    Oresland, Tom
    Ivarsson, Marie-Louise
    JOURNAL OF SURGICAL RESEARCH, 2009, 153 (01) : 46 - 53
  • [38] Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
    Lampelj, Maja
    Arko, Darja
    Cas-Sikosek, Nina
    Kavalar, Rajko
    Ravnik, Maja
    Jezersek-Novakovic, Barbara
    Dobnik, Sarah
    Dovnik, Nina Fokter
    Takac, Iztok
    RADIOLOGY AND ONCOLOGY, 2015, 49 (04) : 357 - 364
  • [39] Pooled analysis of uPA and PAI-1 for prognosis in primary breast cancer patients
    Look, MP
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (01): : 70 - 72
  • [40] uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
    Michael J Duffy
    Patricia M McGowan
    Nadia Harbeck
    Christoph Thomssen
    Manfred Schmitt
    Breast Cancer Research, 16
12345